GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Visgeneer Inc (ROCO:4197) » Definitions » EV-to-FCF

Visgeneer (ROCO:4197) EV-to-FCF : 27.50 (As of May. 22, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Visgeneer EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Visgeneer's Enterprise Value is NT$346.7 Mil. Visgeneer's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was NT$12.6 Mil. Therefore, Visgeneer's EV-to-FCF for today is 27.50.

The historical rank and industry rank for Visgeneer's EV-to-FCF or its related term are showing as below:

ROCO:4197' s EV-to-FCF Range Over the Past 10 Years
Min: -93.98   Med: -15.81   Max: 106.83
Current: 26.66

During the past 13 years, the highest EV-to-FCF of Visgeneer was 106.83. The lowest was -93.98. And the median was -15.81.

ROCO:4197's EV-to-FCF is ranked worse than
67.55% of 376 companies
in the Biotechnology industry
Industry Median: 9.49 vs ROCO:4197: 26.66

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), Visgeneer's stock price is NT$10.45. Visgeneer's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.650. Therefore, Visgeneer's PE Ratio for today is At Loss.


Visgeneer EV-to-FCF Historical Data

The historical data trend for Visgeneer's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visgeneer EV-to-FCF Chart

Visgeneer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.16 -39.31 106.49 8.87 27.62

Visgeneer Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 106.49 - 8.87 - 27.62

Competitive Comparison of Visgeneer's EV-to-FCF

For the Biotechnology subindustry, Visgeneer's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visgeneer's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Visgeneer's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Visgeneer's EV-to-FCF falls into.



Visgeneer EV-to-FCF Calculation

Visgeneer's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=346.675/12.607
=27.50

Visgeneer's current Enterprise Value is NT$346.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Visgeneer's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was NT$12.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visgeneer  (ROCO:4197) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Visgeneer's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10.45/-0.650
=At Loss

Visgeneer's share price for today is NT$10.45.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Visgeneer's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.650.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Visgeneer EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Visgeneer's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Visgeneer (ROCO:4197) Business Description

Traded in Other Exchanges
N/A
Address
Number 335, Sec. 6, Zhonghua Road, Xiangshan District, Hsinchu, TWN, 30094
Visgeneer Inc is a Taiwan based Biotech company involved in developing and, manufacturing biomedical products in the areas of Bacterial Fermentation, Medical Device, Cosmetics/Skin Care, and Cancer Gene identification. Its products include Blood Glucose and Ketone Monitoring System, Ginkgo Biloba series, Peptide-Complex series, Hyaluronic Acid Essence Series and High-Quality Masks among others.

Visgeneer (ROCO:4197) Headlines

No Headlines